It is not intended for human or animal consumption, therapeutic use, or diagnostic purposes
However, peptide therapy is not a one-session intervention
WAKIX is FDA-approved for the treatment of excessive daytime sleepiness or cataplexy in adult patients with narcolepsy and for the treatment of EDS in pediatric patients 6 years of age and older with narcolepsy, but it is not yet approved for Prader-Willi syndrome and remains under evaluation for this condition
Choe J, Archer JS, Shanks AL
TOPICS DISCUSSED: Oxidative Stress: Reactive oxygen species (ROS) generated by mitochondrial metabolism cause damage
So when people talk about GHK-Cu before and after results, theyre really talking about a restoration peptide, not a quick-fix cream